Cluster | Total UMI counts | Global CPM | Transcripts | Categories | Human homolog | Annotation |
---|---|---|---|---|---|---|
MligTC455_44581 | 21 | 0.45 | Mlig455_051467, Mlig455_066697, Mlig455_066705 | Neo: - Age: - |
Mlig455_051467 {REF} {Length: 1757} {Pfam: Amiloride-sensitive sodium channel [PF00858.26, score=143.6]} {Smed: dd_Smed_v6_13556_0_1, dd_Smed_v6_13556_0_1, [Score=50.1, Expect=2e-06]} {RNA1310_22174} {RNA815_24783} Mlig455_066697 {REF} {Length: 2064} {Pfam: Amiloride-sensitive sodium channel [PF00858.26, score=143.7]} {Smed: dd_Smed_v6_13556_0_1, dd_Smed_v6_13556_0_1, [Score=50.1, Expect=3e-06]} {RNA1310_22174} {RNA815_24783} Mlig455_066705 {REF} {Length: 2021} {Pfam: Amiloride-sensitive sodium channel [PF00858.26, score=46.4]} {RNA1310_22174} {RNA815_24783} |
Region | logFC | logCPM | Pvalue | FDR | Specificity |
---|---|---|---|---|---|
RegionR1 | 1.016 | 0.936 | 0.99986 | 1.00000 | |
RegionR2 | 4.107 | 0.936 | 0.99959 | 1.00000 | |
RegionR3 | -1.248 | 0.936 | 0.99993 | 1.00000 | |
RegionR4 | -0.531 | 0.936 | 0.99979 | 1.00000 | |
RegionR5 | -1.358 | 0.936 | 1.00000 | 1.00000 | |
RegionR6 | -1.552 | 0.936 | 0.99989 | 1.00000 | |
RegionR7 | -0.516 | 0.936 | 0.99989 | 1.00000 | |
RegionR8 | 0.082 | 0.936 | 0.99989 | 1.00000 |
Region | logFC | logCPM | PValue | FDR | Specificity |
---|---|---|---|---|---|
RegenerationR1 | -2.104 | 0.936 | 0.99989 | 1.00000 | |
RegenerationR2 | 0.09 | 0.936 | 1.00000 | 1.00000 | |
RegenerationR3 | -1.059 | 0.936 | 0.99991 | 1.00000 | |
RegenerationR4 | -1.036 | 0.936 | 0.99988 | 1.00000 | |
RegenerationR5 | -0.761 | 0.936 | 0.99991 | 1.00000 | |
RegenerationR6 | -0.68 | 0.936 | 0.99994 | 1.00000 | |
RegenerationBL | -1.305 | 0.936 | 0.99993 | 1.00000 | |
RegenerationTP | -0.971 | 0.936 | 0.99991 | 1.00000 |
Nr. | Cluster | Total UMI counts | Global CPM | Transcripts | Categories | Human homolog | Σ Spearman correlations | Int1 | Int2 | Int3 | Reg1 | Reg2 | Reg3 | Annotation |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1. | MligTC455_44581 | 21 | 0.45 | Mlig455_051467, Mlig455_066697, Mlig455_066705 | Neo: - Age: - |
3 | - | - | 1.000 | 1.000 | 1.000 | - | Mlig455_051467 {REF} {Length: 1757} {Pfam: Amiloride-sensitive sodium channel [PF00858.26, score=143.6]} {Smed: dd_Smed_v6_13556_0_1, dd_Smed_v6_13556_0_1, [Score=50.1, Expect=2e-06]} {RNA1310_22174} {RNA815_24783} Mlig455_066697 {REF} {Length: 2064} {Pfam: Amiloride-sensitive sodium channel [PF00858.26, score=143.7]} {Smed: dd_Smed_v6_13556_0_1, dd_Smed_v6_13556_0_1, [Score=50.1, Expect=3e-06]} {RNA1310_22174} {RNA815_24783} Mlig455_066705 {REF} {Length: 2021} {Pfam: Amiloride-sensitive sodium channel [PF00858.26, score=46.4]} {RNA1310_22174} {RNA815_24783} |
|
2. | MligTC455_25556 | 160 | 3.33 | Mlig455_041382 | Neo: - Age: - Region-specific R2: 5.503 Region-enriched R2: 4.706/0.00082 |
2.866 | - | - | 0.966 | 0.995 | 0.905 | - | Mlig455_041382 {REF} {Length: 1197} {RNA1509_55439} {RNA1310_65119, RNA1509_55439} {RNA1509_55439, RNA815_36098.2} | |
3. | MligTC455_34524 | 155 | 3.22 | Mlig455_021291 | Neo: - Age: Down-Up-Down Region-specific R2: 4.905 Region-enriched R2: 4.200/0.01842 |
2.864 | - | - | 0.906 | 0.979 | 0.979 | - | Mlig455_021291 {REF} {Length: 1478} {NoTransDecoderORF} {RNA1509_56543} {RNA1310_26920, RNA1509_56543} {RNA1509_56543, RNA815_11718} | |
4. | MligTC455_23957 | 33 | 0.68 | Mlig455_015196, Mlig455_068736 | Neo: - Age: - Region-enriched R2: 7.683/0.01527 |
2.846 | - | - | 0.980 | 0.914 | 0.952 | - | Mlig455_015196 {REF} {Length: 1138} {Pfam: Concanavalin A-like lectin/glucanases superfamily [PF13385.8, score=63.8]} {RNA1509_30941} {RNA1310_34740} {RNA815_15663} Mlig455_068736 {REF} {Length: 1580} {Pfam: Concanavalin A-like lectin/glucanases superfamily [PF13385.8, score=64.0]} {RNA1310_32395.1} {RNA815_15663} |
|
5. | MligTC455_11619 | 48 | 1 | Mlig455_015930, Mlig455_059692 | Neo: - Age: - |
CPNE3 | 2.826 | - | - | 0.973 | 0.909 | 0.944 | - | Mlig455_015930 {REF} {Length: 2409} {Pfam: C2 domain [PF00168.32, score=33.7]} {Human: ENSG00000085719, CPNE3, copine 3, [Score=87.4, Expect=6e-19]} {Mouse: ENSMUSG00000028228, Cpne3, copine III, [Score=85.5, Expect=2e-18]; ENSMUSG00000074643, Cpne1, copine I, [Score=81.6, Expect=2e-17]} {Celegans: WBGene00012128, nra-1, Nicotinic receptor-associated protein 1, [Score=57.0, Expect=5e-09]} {Smed: dd_Smed_v6_2149_0_4, dd_Smed_v6_2149_0_4, [Score=75.1, Expect=3e-15]} {RNA1310_39685} {RNA815_22508} Mlig455_059692 {REF} {Length: 2378} {Pfam: C2 domain [PF00168.32, score=33.7]} {Human: ENSG00000085719, CPNE3, copine 3, [Score=87.8, Expect=4e-19]} {Mouse: ENSMUSG00000028228, Cpne3, copine III, [Score=85.9, Expect=1e-18]} {Celegans: WBGene00012128, nra-1, Nicotinic receptor-associated protein 1, [Score=55.5, Expect=1e-08]} {Smed: dd_Smed_v6_2149_0_4, dd_Smed_v6_2149_0_4, [Score=75.1, Expect=3e-15]} {RNA1310_39685} {RNA815_22508} |
6. | MligTC455_50927 | 254 | 5.29 | Mlig455_070541, Mlig455_070562 | Neo: - Age: Down-Up-Down, logFC(26M/2M)=-0.296 Region-enriched R2: 7.883/0.00008 |
FZD4 | 2.825 | - | - | 0.952 | 0.937 | 0.936 | - | Mlig455_070541 {REF} {Length: 3522} {Pfam: Frizzled/Smoothened family membrane region [PF01534.19, score=339.1]; Fz domain [PF01392.24, score=88.1]} {Human: ENSG00000174804, FZD4, frizzled class receptor 4, [RH, Score=446, Expect=1e-149]} {Mouse: ENSMUSG00000049791, Fzd4, frizzled class receptor 4, [RH, Score=446, Expect=1e-149]} {Dmel: FBgn0001085, fz, frizzled, [Score=315, Expect=3e-98]} {Celegans: WBGene00000478, cfz-2, Frizzled-2, [Score=284, Expect=5e-87]} {Smed: dd_Smed_v6_7210_0_1, dd_Smed_v6_7210_0_1, [RH, Score=471, Expect=6e-159]} {RNA1509_15834} {RNA1310_3800, RNA1509_15834} {RNA1509_15834, RNA815_19571} Mlig455_070562 {REF} {Length: 3527} {Pfam: Frizzled/Smoothened family membrane region [PF01534.19, score=339.1]; Fz domain [PF01392.24, score=88.1]} {Human: ENSG00000174804, FZD4, frizzled class receptor 4, [RH, Score=446, Expect=1e-149]} {Mouse: ENSMUSG00000049791, Fzd4, frizzled class receptor 4, [RH, Score=446, Expect=2e-149]} {Dmel: FBgn0001085, fz, frizzled, [Score=315, Expect=3e-98]} {Celegans: WBGene00000478, cfz-2, Frizzled-2, [Score=284, Expect=5e-87]} {Smed: dd_Smed_v6_7210_0_1, dd_Smed_v6_7210_0_1, [RH, Score=470, Expect=8e-159]} {RNA1509_15834} {RNA1310_3800} {RNA815_19571} |
7. | MligTC455_21757 | 26 | 0.53 | Mlig455_057867 | Neo: - Age: - |
2.807 | - | - | 0.948 | 0.964 | 0.895 | - | Mlig455_057867 {REF} {Length: 284} {NoTransDecoderORF} {RNA1310_117997} | |
8. | MligTC455_19716 | 35 | 0.73 | Mlig455_008148 | Neo: - Age: - |
NPY1R | 2.795 | - | - | 0.868 | 0.954 | 0.973 | - | Mlig455_008148 {REF} {Length: 3212} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=183.4]; Serpentine type 7TM GPCR chemoreceptor Srsx [PF10320.11, score=46.8]; Serpentine type 7TM GPCR chemoreceptor Srx [PF10328.11, score=36.4]} {Human: ENSG00000164128, NPY1R, neuropeptide Y receptor Y1, [RH, Score=167, Expect=8e-47]} {Mouse: ENSMUSG00000031932, Gpr83, G protein-coupled receptor 83, [RH, Score=170, Expect=8e-48]; ENSMUSG00000036437, Npy1r, neuropeptide Y receptor Y1, [RH, Score=167, Expect=7e-47]} {Dmel: FBgn0036934, sNPF-R, short neuropeptide F receptor, [RH, Score=256, Expect=1e-78]} {Celegans: WBGene00009619, npr-6, NeuroPeptide Receptor family, [RH, Score=220, Expect=3e-67]} {Smed: dd_Smed_v6_10020_0_1, dd_Smed_v6_10020_0_1, [RH, Score=336, Expect=1e-112]} {RNA1310_21371} {RNA815_7986} |
9. | MligTC455_45811 | 216 | 4.5 | Mlig455_015628 | Neo: - Age: Down-Up-Down Region-enriched R2: 5.807/0.00004 |
2.788 | - | - | 0.945 | 0.974 | 0.869 | - | Mlig455_015628 {REF} {Length: 1061} {RNA1310_43338} {RNA815_24238} | |
10. | MligTC455_44328 | 858 | 17.88 | Mlig455_026172 | Neo: - Age: Down-Up-Up Region-specific R2: 4.714 Region-enriched R2: 4.385/0.00000 |
2.785 | - | - | 0.955 | 0.983 | 0.847 | - | Mlig455_026172 {REF} {Length: 661} {RNA1509_32102, RNA1509_34635} {RNA1310_60068, RNA1509_32102, RNA1509_34635} {RNA1509_32102, RNA1509_34635, RNA815_37486} | |
11. | MligTC455_50172 | 243 | 5.05 | Mlig455_067182 | Neo: - Age: Down-Up-Up Region-specific R2: 6.036 Region-enriched R2: 6.524/0.00000 |
2.784 | - | - | 0.978 | 0.985 | 0.821 | - | Mlig455_067182 {REF} {Length: 638} {Pfam: Pancreatic hormone peptide [PF00159.20, score=47.5]} {RNA1509_60030} {RNA1310_56761, RNA1509_60030} {RNA1509_60030, RNA815_31877.1} | |
12. | MligTC455_26519 | 183 | 3.82 | Mlig455_030983, Mlig455_069440 | Neo: - Age: - |
2.782 | - | - | 0.975 | 0.987 | 0.820 | - | Mlig455_030983 {REF} {Length: 688} {RNA1509_12904} {RNA1310_62229} {RNA815_56172} Mlig455_069440 {REF} {Length: 1096} {Pfam: Reverse transcriptase (RNA-dependent DNA polymerase) [PF00078.29, score=54.9]} {RNA1509_35362} {RNA1310_21423.2} {RNA815_13686} |
|
13. | MligTC455_50601 | 21 | 0.44 | Mlig455_018462 | Neo: - Age: - |
2.778 | - | - | 1.000 | 0.851 | 0.927 | - | Mlig455_018462 {REF} {Length: 2878} {Pfam: Amiloride-sensitive sodium channel [PF00858.26, score=164.0]} {Smed: dd_Smed_v6_37545_0_1, dd_Smed_v6_37545_0_1, [Score=117, Expect=1e-27]} {RNA1310_8235} {RNA815_10456.1} | |
14. | MligTC455_45350 | 92 | 1.93 | Mlig455_024760, Mlig455_058317, Mlig455_068656 | Neo: - Age: Up-Down-Down |
SLC17A6, SLC17A8 | 2.773 | - | - | 0.905 | 0.958 | 0.910 | - | Mlig455_024760 {REF} {Length: 2935} {Pfam: Major Facilitator Superfamily [PF07690.18, score=158.2]} {Human: ENSG00000179520, SLC17A8, solute carrier family 17 member 8, [RH, Score=531, Expect=0.0]; ENSG00000091664, SLC17A6, solute carrier family 17 member 6, [RH, Score=531, Expect=0.0]; ENSG00000104888, SLC17A7, solute carrier family 17 member 7, [RH, Score=522, Expect=5e-180]} {Mouse: ENSMUSG00000019935, Slc17a8, solute carrier family 17 (sodium-dependent inorganic phosphate cotransporter), member 8, [RH, Score=536, Expect=0.0]; ENSMUSG00000030500, Slc17a6, solute carrier family 17 (sodium-dependent inorganic phosphate cotransporter), member 6, [RH, Score=530, Expect=0.0]; ENSMUSG00000070570, Slc17a7, solute carrier family 17 (sodium-dependent inorganic phosphate cotransporter), member 7, [RH, Score=527, Expect=0.0]} {Dmel: FBgn0031424, VGlut, Vesicular glutamate transporter, [Score=487, Expect=1e-165]} {Celegans: WBGene00001135, eat-4, Probable vesicular glutamate transporter eat-4, [RH, Score=474, Expect=3e-161]} {Smed: dd_Smed_v6_10192_0_1, dd_Smed_v6_10192_0_1, [RH, Score=583, Expect=0.0]} {RNA1310_14405.1} {RNA815_24257} Mlig455_058317 {REF} {Length: 2971} {Pfam: Major Facilitator Superfamily [PF07690.18, score=157.7]} {Human: ENSG00000091664, SLC17A6, solute carrier family 17 member 6, [RH, Score=534, Expect=0.0]; ENSG00000179520, SLC17A8, solute carrier family 17 member 8, [RH, Score=531, Expect=0.0]; ENSG00000104888, SLC17A7, solute carrier family 17 member 7, [RH, Score=521, Expect=8e-180]} {Mouse: ENSMUSG00000019935, Slc17a8, solute carrier family 17 (sodium-dependent inorganic phosphate cotransporter), member 8, [RH, Score=536, Expect=0.0]; ENSMUSG00000030500, Slc17a6, solute carrier family 17 (sodium-dependent inorganic phosphate cotransporter), member 6, [RH, Score=531, Expect=0.0]; ENSMUSG00000070570, Slc17a7, solute carrier family 17 (sodium-dependent inorganic phosphate cotransporter), member 7, [RH, Score=526, Expect=0.0]} {Dmel: FBgn0031424, VGlut, Vesicular glutamate transporter, [Score=485, Expect=1e-164]} {Celegans: WBGene00001135, eat-4, Probable vesicular glutamate transporter eat-4, [Score=474, Expect=7e-162]} {Smed: dd_Smed_v6_10192_0_1, dd_Smed_v6_10192_0_1, [Score=585, Expect=0.0]} {RNA1310_14405.1} {RNA815_24257} Mlig455_068656 {REF} {Length: 3034} {Pfam: Major Facilitator Superfamily [PF07690.18, score=158.2]} {Human: ENSG00000179520, SLC17A8, solute carrier family 17 member 8, [RH, Score=531, Expect=0.0]; ENSG00000091664, SLC17A6, solute carrier family 17 member 6, [RH, Score=531, Expect=0.0]; ENSG00000104888, SLC17A7, solute carrier family 17 member 7, [RH, Score=522, Expect=5e-180]} {Mouse: ENSMUSG00000019935, Slc17a8, solute carrier family 17 (sodium-dependent inorganic phosphate cotransporter), member 8, [RH, Score=536, Expect=0.0]; ENSMUSG00000030500, Slc17a6, solute carrier family 17 (sodium-dependent inorganic phosphate cotransporter), member 6, [RH, Score=530, Expect=0.0]; ENSMUSG00000070570, Slc17a7, solute carrier family 17 (sodium-dependent inorganic phosphate cotransporter), member 7, [RH, Score=527, Expect=0.0]} {Dmel: FBgn0031424, VGlut, Vesicular glutamate transporter, [Score=487, Expect=1e-165]} {Celegans: WBGene00001135, eat-4, Probable vesicular glutamate transporter eat-4, [RH, Score=474, Expect=3e-161]} {Smed: dd_Smed_v6_10192_0_1, dd_Smed_v6_10192_0_1, [RH, Score=583, Expect=0.0]} {RNA1310_14405.1} {RNA815_24257} |
15. | MligTC455_50602 | 84 | 1.74 | Mlig455_065088 | Neo: - Age: - |
2.766 | - | - | 0.981 | 0.962 | 0.823 | - | Mlig455_065088 {REF} {Length: 2765} {Pfam: Amiloride-sensitive sodium channel [PF00858.26, score=129.5]} {Smed: dd_Smed_v6_37545_0_1, dd_Smed_v6_37545_0_1, [Score=67.8, Expect=6e-12]} {RNA1310_8235} {RNA815_10456.1} | |
16. | MligTC455_50778 | 36 | 0.76 | Mlig455_042296 | Neo: - Age: - |
GPR50 | 2.76 | - | - | 0.992 | 0.954 | 0.814 | - | Mlig455_042296 {REF} {Length: 1415} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=116.3]; Serpentine type 7TM GPCR chemoreceptor Srx [PF10328.11, score=40.0]; Olfactory receptor [PF13853.8, score=34.3]; Serpentine type 7TM GPCR chemoreceptor Srsx [PF10320.11, score=33.9]} {Human: ENSG00000102195, GPR50, G protein-coupled receptor 50, [Score=124, Expect=4e-31]; ENSG00000134640, MTNR1B, melatonin receptor 1B, [Score=119, Expect=2e-30]} {Mouse: ENSMUSG00000054764, Mtnr1a, melatonin receptor 1A, [Score=120, Expect=4e-31]; ENSMUSG00000056380, Gpr50, G-protein-coupled receptor 50, [Score=119, Expect=2e-29]; ENSMUSG00000050901, Mtnr1b, melatonin receptor 1B, [Score=118, Expect=5e-30]} {Dmel: FBgn0038980, Octbeta1R, Octopamine beta1 receptor, [Score=92.0, Expect=1e-20]} {Celegans: WBGene00006428, tkr-3, TachyKinin Receptor family, [Score=69.7, Expect=4e-13]} {Smed: dd_Smed_v6_65999_0_1, dd_Smed_v6_65999_0_1, [Score=84.7, Expect=1e-18]} {RNA1310_66047} {RNA815_34066} |
17. | MligTC455_24569 | 17 | 0.35 | Mlig455_039795 | Neo: - Age: - |
CACNA2D2 | 2.757 | - | - | 0.868 | 0.927 | 0.962 | - | Mlig455_039795 {REF} {Length: 4369} {Pfam: VWA N-terminal [PF08399.13, score=79.6]; Cache domain [PF02743.20, score=54.9]; von Willebrand factor type A domain [PF13519.8, score=37.5]; von Willebrand factor type A domain [PF00092.30, score=32.3]; von Willebrand factor type A domain [PF13768.8, score=27.8]} {Human: ENSG00000007402, CACNA2D2, calcium voltage-gated channel auxiliary subunit alpha2delta 2, [Score=182, Expect=5e-46]; ENSG00000153956, CACNA2D1, calcium voltage-gated channel auxiliary subunit alpha2delta 1, [Score=176, Expect=3e-44]; ENSG00000157445, CACNA2D3, calcium voltage-gated channel auxiliary subunit alpha2delta 3, [Score=174, Expect=2e-43]} {Mouse: ENSMUSG00000010066, Cacna2d2, calcium channel, voltage-dependent, alpha 2/delta subunit 2, [Score=182, Expect=3e-46]; ENSMUSG00000040118, Cacna2d1, calcium channel, voltage-dependent, alpha2/delta subunit 1, [Score=177, Expect=1e-44]; ENSMUSG00000021991, Cacna2d3, calcium channel, voltage-dependent, alpha2/delta subunit 3, [Score=176, Expect=3e-44]} {Dmel: FBgn0028863, CG4587, [Score=149, Expect=5e-36]} {Celegans: WBGene00007041, tag-180, [Score=110, Expect=4e-24]} {Smed: dd_Smed_v6_19048_0_1, dd_Smed_v6_19048_0_1, [RH, Score=1452, Expect=0.0]} {RNA1509_28096} {RNA1310_2030} {RNA815_1872} |
18. | MligTC455_52656 | 121 | 2.51 | Mlig455_062381, Mlig455_062408 | Neo: - Age: Down-Up-Down |
2.757 | - | - | 0.759 | 1.000 | 0.998 | - | Mlig455_062381 {REF} {Length: 2245} {RNA1310_26272} {RNA815_22826} Mlig455_062408 {REF} {Length: 2277} {RNA1310_26272} {RNA815_37592} |
|
19. | MligTC455_50806 | 257 | 5.36 | Mlig455_028471 | Neo: - Age: Up-Down-Up Region-specific R2: 3.748 Region-enriched R2: 3.524/0.00051 Regeneration-downregulated R2: -2.091 Regeneration-depleted R2: -2.091 |
2.752 | - | - | 0.966 | 0.962 | 0.824 | - | Mlig455_028471 {REF} {Length: 923} {Pfam: Pancreatic hormone peptide [PF00159.20, score=41.0]} {RNA1509_25155} {RNA1310_44043} {RNA815_21709} | |
20. | MligTC455_24523 | 144 | 2.99 | Mlig455_010636, Mlig455_010724 | Neo: - Age: - Region-enriched R2: 9.355/0.00000 |
RGS6 | 2.747 | - | - | 0.792 | 0.987 | 0.968 | - | Mlig455_010636 {REF} {Length: 2512} {Pfam: Regulator of G-protein signalling DHEX domain [PF18148.3, score=118.4]; Regulator of G protein signaling domain [PF00615.21, score=116.4]; Domain found in Dishevelled, Egl-10, and Pleckstrin (DEP) [PF00610.23, score=31.3]} {Human: ENSG00000182732, RGS6, regulator of G protein signaling 6, [Score=301, Expect=3e-95]} {Mouse: ENSMUSG00000021219, Rgs6, regulator of G-protein signaling 6, [Score=299, Expect=2e-94]; ENSMUSG00000026527, Rgs7, regulator of G protein signaling 7, [Score=290, Expect=6e-91]} {Dmel: FBgn0259927, CG42450, [RH, Score=327, Expect=2e-98]} {Celegans: WBGene00001145, eat-16, [Score=217, Expect=1e-63]} {Smed: dd_Smed_v6_5311_0_1, dd_Smed_v6_5311_0_1, [RH, Score=384, Expect=1e-127]} {RNA1509_59108} {RNA1310_13711, RNA1509_59108} {RNA1509_59108, RNA815_9935} Mlig455_010724 {REF} {Length: 2512} {Pfam: Regulator of G-protein signalling DHEX domain [PF18148.3, score=118.4]; Regulator of G protein signaling domain [PF00615.21, score=113.1]; Domain found in Dishevelled, Egl-10, and Pleckstrin (DEP) [PF00610.23, score=31.3]} {Human: ENSG00000182732, RGS6, regulator of G protein signaling 6, [Score=299, Expect=2e-94]} {Mouse: ENSMUSG00000021219, Rgs6, regulator of G-protein signaling 6, [Score=297, Expect=2e-93]; ENSMUSG00000026527, Rgs7, regulator of G protein signaling 7, [Score=287, Expect=4e-90]} {Dmel: FBgn0259927, CG42450, [RH, Score=324, Expect=1e-97]} {Celegans: WBGene00001145, eat-16, [Score=214, Expect=8e-63]} {Smed: dd_Smed_v6_5311_0_1, dd_Smed_v6_5311_0_1, [RH, Score=382, Expect=8e-127]} {RNA1509_59108} {RNA1310_13711} {RNA815_9935} |
21. | MligTC455_33832 | 112 | 2.34 | Mlig455_029411 | Neo: - Age: Up-Down-Down Region-enriched R2: 5.300/0.00016 |
GLRA3 | 2.743 | - | - | 0.976 | 0.810 | 0.957 | - | Mlig455_029411 {REF} {Length: 3686} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=149.0]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=84.5]} {Human: ENSG00000145451, GLRA3, glycine receptor alpha 3, [Score=257, Expect=5e-80]; ENSG00000145888, GLRA1, glycine receptor alpha 1, [Score=253, Expect=3e-78]; ENSG00000101958, GLRA2, glycine receptor alpha 2, [Score=250, Expect=4e-77]} {Mouse: ENSMUSG00000038257, Glra3, glycine receptor, alpha 3 subunit, [Score=251, Expect=2e-77]; ENSMUSG00000018589, Glra2, glycine receptor, alpha 2 subunit, [Score=249, Expect=5e-77]; ENSMUSG00000000263, Glra1, glycine receptor, alpha 1 subunit, [Score=248, Expect=2e-76]; ENSMUSG00000018595, Glra4, glycine receptor, alpha 4 subunit, [Score=243, Expect=1e-74]} {Dmel: FBgn0024963, GluClalpha, [Score=253, Expect=2e-78]} {Celegans: WBGene00000233, avr-15, GluClalpha2B protein, [Score=259, Expect=7e-81]} {Smed: dd_Smed_v6_11342_0_1, dd_Smed_v6_11342_0_1, [RH, Score=480, Expect=1e-167]} {RNA1509_35986} {RNA1310_35528} {RNA815_35433} |
22. | MligTC455_43602 | 1418 | 29.54 | Mlig455_053986 | Neo: - Age: - Region-specific R2: 4.626 Region-enriched R2: 3.844/0.00000 Regeneration-downregulated R2: -2.432 Regeneration-depleted R2: -2.432 |
2.743 | - | - | 0.969 | 0.977 | 0.797 | - | Mlig455_053986 {REF} {Length: 2161} {RNA1509_15576} {RNA1310_12096.1} {RNA815_32931} | |
23. | MligTC455_25268 | 55 | 1.15 | Mlig455_000562, Mlig455_030361 | Neo: - Age: - Region-enriched R2: 7.728/0.00671 |
2.741 | - | - | 0.855 | 0.976 | 0.910 | - | Mlig455_000562 {REF} {Length: 844} {Pfam: DNA gyrase inhibitor YacG [PF03884.16, score=19.0]} {RNA1310_51946} {RNA815_48498} Mlig455_030361 {REF} {Length: 1237} {Pfam: DNA gyrase inhibitor YacG [PF03884.16, score=18.5]} {RNA1509_24858} {RNA1310_51946} {RNA815_48498} |
|
24. | MligTC455_18599 | 119 | 2.47 | Mlig455_031197 | Neo: - Age: Down-Up-Up Region-enriched R2: 4.553/0.00808 |
2.737 | - | - | 0.966 | 0.948 | 0.823 | - | Mlig455_031197 {REF} {Length: 1284} {RNA1310_35452} | |
25. | MligTC455_40781 | 153 | 3.2 | Mlig455_024109, Mlig455_063982 | Neo: - Age: - |
2.737 | - | - | 0.987 | 0.987 | 0.763 | - | Mlig455_024109 {REF} {Length: 1081} {RNA1509_16458} {RNA1310_43664.1, RNA1509_16458} {RNA1509_16458, RNA815_23166} Mlig455_063982 {REF} {Length: 3562} {RNA1509_16458} {RNA1310_30070} {RNA815_23166} |
|
26. | MligTC455_50777 | 40 | 0.83 | Mlig455_042072 | Neo: - Age: - |
MTNR1B | 2.736 | - | - | 0.995 | 0.939 | 0.802 | - | Mlig455_042072 {REF} {Length: 2881} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=78.0]; Olfactory receptor [PF13853.8, score=24.3]; Serpentine type 7TM GPCR chemoreceptor Srsx [PF10320.11, score=22.0]} {Human: ENSG00000134640, MTNR1B, melatonin receptor 1B, [Score=94.4, Expect=2e-21]; ENSG00000168412, MTNR1A, melatonin receptor 1A, [Score=90.1, Expect=5e-20]} {Mouse: ENSMUSG00000050901, Mtnr1b, melatonin receptor 1B, [Score=94.0, Expect=2e-21]; ENSMUSG00000054764, Mtnr1a, melatonin receptor 1A, [Score=89.4, Expect=6e-20]} {Dmel: FBgn0004514, Oct-TyrR, Octopamine-Tyramine receptor, [Score=57.0, Expect=7e-09]} {Celegans: WBGene00006428, tkr-3, TachyKinin Receptor family, [Score=52.0, Expect=2e-07]} {Smed: dd_Smed_v6_19535_0_1, dd_Smed_v6_19535_0_1, [Score=95.5, Expect=2e-22]} {RNA1310_66047} {RNA815_34066} |
27. | MligTC455_25701 | 31 | 0.65 | Mlig455_017477 | Neo: - Age: - |
2.729 | - | - | 0.972 | 0.975 | 0.782 | - | Mlig455_017477 {REF} {Length: 664} {RNA1310_52753} {RNA815_26527} | |
28. | MligTC455_41823 | 300 | 6.25 | Mlig455_022277 | Neo: - Age: - Region-enriched R2: 3.150/0.00185 |
2.728 | - | - | 0.956 | 0.981 | 0.791 | - | Mlig455_022277 {REF} {Length: 753} {RNA1509_49797} {RNA1310_60350} {RNA815_30999} | |
29. | MligTC455_41036 | 281 | 5.86 | Mlig455_057198 | Neo: - Age: - Region-specific R2: 5.284 Region-enriched R2: 4.243/0.00075 |
2.723 | - | - | 0.956 | 0.967 | 0.800 | - | Mlig455_057198 {REF} {Length: 538} {Pfam: Pancreatic hormone peptide [PF00159.20, score=41.9]} {RNA1509_42071} {RNA1310_74103, RNA1509_42071} {RNA1509_42071, RNA815_38377} | |
30. | MligTC455_25766 | 42 | 0.88 | Mlig455_008785, Mlig455_008821, Mlig455_008919 | Neo: - Age: - Region-enriched R2: 5.588/0.00166 |
2.722 | - | - | 0.985 | 0.988 | 0.749 | - | Mlig455_008785 {REF} {Length: 1744} {RNA1310_20437} {RNA815_15201} Mlig455_008821 {REF} {Length: 2074} {RNA1310_20437} {RNA815_15201} Mlig455_008919 {REF} {Length: 2074} {RNA1310_20437} {RNA815_15201} |
|
31. | MligTC455_50567 | 146 | 3.04 | Mlig455_012858 | Neo: - Age: - Region-specific R2: 6.162 Region-enriched R2: 5.988/0.01054 |
2.72 | - | - | 0.935 | 0.796 | 0.989 | - | Mlig455_012858 {REF} {Length: 1282} {Pfam: F5/8 type C domain [PF00754.27, score=27.5]} {Smed: dd_Smed_v6_36585_0_1, dd_Smed_v6_36585_0_1, [RH, Score=64.3, Expect=4e-12]} {RNA1310_34633} {RNA815_12537} | |
32. | MligTC455_29586 | 237 | 4.95 | Mlig455_024687, Mlig455_024712 | Neo: - Age: - Region-specific R2: 5.384 Region-enriched R2: 6.584/0.00000 |
2.718 | - | - | 0.955 | 0.956 | 0.807 | - | Mlig455_024687 {REF} {Length: 1636} {RNA1509_26262} {RNA1310_30838} {RNA815_35621} Mlig455_024712 {REF} {Length: 1612} {RNA1509_26262} {RNA1310_30838} {RNA815_35621} |
|
33. | MligTC455_19410 | 194 | 4.04 | Mlig455_047838 | Neo: - Age: Down-Up-Up Region-specific R2: 5.170 Region-enriched R2: 5.689/0.00000 |
2.715 | - | - | 0.983 | 0.994 | 0.738 | - | Mlig455_047838 {REF} {Length: 724} {TRANSSPLICED} {RNA1509_54915} {RNA1310_53549} {RNA815_27051} | |
34. | MligTC455_38838 | 24 | 0.49 | Mlig455_033571, Mlig455_067059 | Neo: - Age: - |
2.715 | - | - | 0.877 | 0.841 | 0.997 | - | Mlig455_033571 {REF} {Length: 1596} {Pfam: Glycosyltransferase sugar-binding region containing DXD motif [PF04488.17, score=62.5]; Capsular polysaccharide synthesis protein [PF05704.14, score=18.7]} {Smed: dd_Smed_v6_42389_0_1, dd_Smed_v6_42389_0_1, [RH, Score=144, Expect=1e-39]} {RNA1310_19511} {RNA815_7578} Mlig455_067059 {REF} {Length: 1559} {Pfam: Glycosyltransferase sugar-binding region containing DXD motif [PF04488.17, score=62.5]; Capsular polysaccharide synthesis protein [PF05704.14, score=18.7]} {Smed: dd_Smed_v6_42389_0_1, dd_Smed_v6_42389_0_1, [RH, Score=144, Expect=1e-39]} {RNA1310_19511} {RNA815_7578} |
|
35. | MligTC455_49824 | 466 | 9.71 | Mlig455_036536 | Neo: - Age: - Region-specific R2: 4.841 Region-enriched R2: 3.862/0.00010 |
2.713 | - | - | 0.917 | 0.990 | 0.806 | - | Mlig455_036536 {REF} {Length: 1139} {Pfam: Nucleoporin FG repeat region [PF13634.8, score=21.2]} {Celegans: WBGene00003748, nlp-10, Neuropeptide-Like Protein, [RH, Score=49.3, Expect=7e-08]} {RNA1509_18714, RNA1509_59524} {RNA1310_41906, RNA1509_18714, RNA1509_59524} {RNA1509_18714, RNA1509_59524, RNA815_24488} | |
36. | MligTC455_44329 | 510 | 10.62 | Mlig455_026184, Mlig455_026199 | Neo: - Age: - Region-specific R2: 5.127 Region-enriched R2: 4.824/0.00000 |
2.707 | - | - | 0.972 | 0.967 | 0.768 | - | Mlig455_026184 {REF} {Length: 724} {RNA1509_29216, RNA1509_32102} {RNA1310_60068, RNA1509_29216} {RNA1509_29216, RNA815_37486} Mlig455_026199 {REF} {Length: 531} {RNA1509_32102} {RNA1310_60068} {RNA815_37486} |
|
37. | MligTC455_33463 | 240 | 4.99 | Mlig455_023684 | Neo: - Age: Up-Down-Down Region-enriched R2: 6.110/0.00054 |
PKD1L2 | 2.704 | - | - | 0.925 | 0.820 | 0.959 | - | Mlig455_023684 {REF} {Length: 12137} {Pfam: Polycystin cation channel [PF08016.14, score=271.5]; PKD domain [PF00801.22, score=88.3]; PLAT/LH2 domain [PF01477.25, score=72.6]; PKD domain [PF18911.2, score=49.9]; Ion transport protein [PF00520.33, score=46.0]; F5/8 type C domain [PF00754.27, score=33.9]} {Human: ENSG00000166473, PKD1L2, polycystin 1 like 2 (gene/pseudogene), [RH, Score=263, Expect=2e-69]} {Mouse: ENSMUSG00000034416, Pkd1l2, polycystic kidney disease 1 like 2, [Score=272, Expect=3e-72]} {Dmel: FBgn0050048, CG30048, [Score=57.4, Expect=3e-07]} {Celegans: WBGene00003058, lov-1, Location of vulva defective 1, [Score=144, Expect=2e-33]} {Smed: dd_Smed_v6_15525_0_2, dd_Smed_v6_15525_0_2, [Score=518, Expect=3e-147]} {RNA1509_5488} {RNA1310_100} {RNA815_3211} |
38. | MligTC455_44713 | 661 | 13.77 | Mlig455_048154 | Neo: - Age: logFC(26M/2M)=0.569 Region-specific R2: 3.883 Region-enriched R2: 3.422/0.00000 |
2.703 | - | - | 0.933 | 0.976 | 0.794 | - | Mlig455_048154 {REF} {Length: 1173} {RNA1509_34252} {RNA1310_54269.1} {RNA815_55074} | |
39. | MligTC455_08763 | 20 | 0.41 | Mlig455_061186 | Neo: - Age: - |
2.696 | - | - | 0.786 | 0.938 | 0.972 | - | Mlig455_061186 {REF} {Length: 1077} {Smed: dd_Smed_v6_13791_0_1, dd_Smed_v6_13791_0_1, [Score=96.3, Expect=3e-24]} {RNA1310_122132} | |
40. | MligTC455_33831 | 198 | 4.13 | Mlig455_029369 | Neo: - Age: - Region-enriched R2: 3.223/0.02852 Regeneration-downregulated TP: -7.340 Regeneration-depleted TP: -7.340 |
GLRA3 | 2.693 | - | - | 0.851 | 0.951 | 0.891 | - | Mlig455_029369 {REF} {Length: 3665} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=149.0]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=84.5]} {Human: ENSG00000145451, GLRA3, glycine receptor alpha 3, [Score=257, Expect=5e-80]; ENSG00000145888, GLRA1, glycine receptor alpha 1, [Score=253, Expect=2e-78]; ENSG00000101958, GLRA2, glycine receptor alpha 2, [Score=250, Expect=4e-77]} {Mouse: ENSMUSG00000038257, Glra3, glycine receptor, alpha 3 subunit, [Score=251, Expect=2e-77]; ENSMUSG00000018589, Glra2, glycine receptor, alpha 2 subunit, [Score=249, Expect=3e-77]; ENSMUSG00000000263, Glra1, glycine receptor, alpha 1 subunit, [Score=248, Expect=1e-76]; ENSMUSG00000018595, Glra4, glycine receptor, alpha 4 subunit, [Score=243, Expect=1e-74]} {Dmel: FBgn0024963, GluClalpha, [Score=253, Expect=2e-78]} {Celegans: WBGene00000233, avr-15, GluClalpha2B protein, [Score=259, Expect=5e-81]} {Smed: dd_Smed_v6_11342_0_1, dd_Smed_v6_11342_0_1, [RH, Score=480, Expect=2e-167]} {RNA1509_35986} {RNA1310_35528} {RNA815_11925.1} |
41. | MligTC455_20154 | 22 | 0.45 | Mlig455_002425 | Neo: - Age: - |
OTOP2 | 2.688 | - | - | 0.760 | 0.953 | 0.975 | - | Mlig455_002425 {REF} {Length: 2659} {Pfam: Otopetrin [PF03189.15, score=233.1]} {Human: ENSG00000183034, OTOP2, otopetrin 2, [Score=55.1, Expect=3e-07]} {Mouse: ENSMUSG00000050201, Otop2, otopetrin 2, [Score=62.4, Expect=1e-09]} {Dmel: FBgn0259150, CG42265, [Score=197, Expect=2e-52]} {Celegans: WBGene00015035, otpl-1, OToPetrin-Like, [Score=117, Expect=6e-27]} {Smed: dd_Smed_v6_13612_0_4, dd_Smed_v6_13612_0_4, [Score=296, Expect=3e-91]} {RNA1310_52344} {RNA815_48323} |
42. | MligTC455_46886 | 51 | 1.05 | Mlig455_015258 | Neo: - Age: - Region-enriched R2: 4.468/0.04690 |
PRKG2 | 2.686 | - | - | 0.998 | 0.924 | 0.764 | - | Mlig455_015258 {REF} {Length: 3110} {Pfam: Protein kinase domain [PF00069.27, score=225.4]; Cyclic nucleotide-binding domain [PF00027.31, score=118.6]; Protein tyrosine and serine/threonine kinase [PF07714.19, score=117.9]; Kinase-like [PF14531.8, score=25.3]} {Human: ENSG00000138669, PRKG2, protein kinase cGMP-dependent 2, [RH, Score=668, Expect=0.0]} {Mouse: ENSMUSG00000029334, Prkg2, protein kinase, cGMP-dependent, type II, [RH, Score=669, Expect=0.0]} {Dmel: FBgn0000442, Pkg21D, Protein kinase, cGMP-dependent at 21D, [RH, Score=683, Expect=0.0]} {Celegans: WBGene00001173, egl-4, cGMP-dependent protein kinase egl-4, [Score=667, Expect=0.0]} {Smed: dd_Smed_v6_6967_0_1, dd_Smed_v6_6967_0_1, [RH, Score=672, Expect=0.0]} {RNA1509_26653} {RNA1310_15330.1} {RNA815_26005} |
43. | MligTC455_48756 | 622 | 12.96 | Mlig455_054772, Mlig455_054799, Mlig455_054893 | Neo: - Age: - Region-specific R2: 7.873 Region-enriched R2: 9.003/0.00000 |
2.68 | - | - | 0.859 | 0.954 | 0.867 | - | Mlig455_054772 {REF} {Length: 716} {RNA1509_41507} {RNA1310_49516} {RNA815_28703} Mlig455_054799 {REF} {Length: 625} {RNA1509_41507} {RNA1310_49516} {RNA815_28703} Mlig455_054893 {REF} {Length: 947} {RNA1509_41507} {RNA1310_49516, RNA1509_41507} {RNA1509_41507, RNA815_28703} |
|
44. | MligTC455_44712 | 665 | 13.86 | Mlig455_017186 | Neo: - Age: Down-Up-Up, logFC(26M/2M)=0.471 Region-specific R2: 4.141 Region-enriched R2: 3.536/0.00000 |
2.679 | - | - | 0.935 | 0.957 | 0.787 | - | Mlig455_017186 {REF} {Length: 1018} {RNA1509_34252} {RNA1310_54269.1} {RNA815_55074} | |
45. | MligTC455_11558 | 137 | 2.85 | Mlig455_058259 | Neo: - Age: logFC(26M/2M)=-0.792 |
2.676 | - | - | 0.982 | 0.982 | 0.712 | - | Mlig455_058259 {REF} {Length: 896} {Pfam: Insulin/IGF/Relaxin family [PF00049.20, score=19.9]} {RNA1509_58923} {RNA1310_41706, RNA1509_58923} {RNA1509_58923, RNA815_20876} | |
46. | MligTC455_45912 | 1103 | 22.98 | Mlig455_006912 | Neo: - Age: - Region-specific R2: 3.366 Region-enriched R2: 1.790/0.00307 |
2.671 | - | - | 0.912 | 0.973 | 0.786 | - | Mlig455_006912 {REF} {Length: 1066} {RNA1509_32903, RNA1509_42927} {RNA1310_38334, RNA1509_42927} {RNA1509_42927, RNA815_18393} | |
47. | MligTC455_36567 | 18 | 0.37 | Mlig455_065030 | Neo: - Age: - |
2.67 | - | - | 0.836 | 0.984 | 0.850 | - | Mlig455_065030 {REF} {Length: 672} | |
48. | MligTC455_25313 | 529 | 11.03 | Mlig455_047806, Mlig455_047883 | Neo: - Age: Up-Down-Down |
PCLO | 2.669 | - | - | 0.868 | 0.964 | 0.837 | - | Mlig455_047806 {REF} {Length: 4640} {Pfam: C2 domain [PF00168.32, score=102.8]; PDZ domain [PF17820.3, score=23.7]} {Human: ENSG00000186472, PCLO, piccolo presynaptic cytomatrix protein, [Score=115, Expect=2e-25]} {Mouse: ENSMUSG00000061601, Pclo, piccolo (presynaptic cytomatrix protein), [RH, Score=117, Expect=4e-26]} {Dmel: FBgn0003091, Pkc53E, Protein C kinase 53E, [Score=83.2, Expect=4e-16]} {Celegans: WBGene00004033, pkc-2, Protein kinase C-like 2, [Score=79.0, Expect=7e-15]} {Smed: dd_Smed_v6_9615_0_2, dd_Smed_v6_9615_0_2, [RH, Score=198, Expect=2e-52]} {RNA1509_12877} {RNA1310_21392} {RNA815_8186} Mlig455_047883 {REF} {Length: 3110} {Smed: dd_Smed_v6_9615_0_2, dd_Smed_v6_9615_0_2, [RH, Score=192, Expect=2e-55]} {RNA1509_12877} {RNA1310_21392} {RNA815_8186} |
49. | MligTC455_49663 | 245 | 5.1 | Mlig455_013565 | Neo: - Age: - |
CDH23 | 2.665 | - | - | 0.766 | 0.951 | 0.948 | - | Mlig455_013565 {REF} {Length: 7289} {Pfam: Cadherin domain [PF00028.19, score=361.2]; Cadherin-like [PF08266.14, score=38.9]} {Human: ENSG00000107736, CDH23, cadherin related 23, [Score=372, Expect=1e-103]} {Mouse: ENSMUSG00000012819, Cdh23, cadherin 23 (otocadherin), [Score=375, Expect=6e-105]} {Dmel: FBgn0038247, Cad88C, Cadherin 88C, [Score=362, Expect=2e-101]} {Celegans: WBGene00001475, fmi-1, FlaMIngo (Cadherin plus 7TM domain) homolog; Flamingo-like protein FMI-1, [Score=224, Expect=2e-58]} {Smed: dd_Smed_v6_15356_0_1, dd_Smed_v6_15356_0_1, [Score=414, Expect=3e-118]} {RNA1509_16482} {RNA1310_682} {RNA815_249} |
50. | MligTC455_53860 | 202 | 4.22 | Mlig455_053523, Mlig455_061000 | Neo: - Age: Up-Down-Down Region-enriched R2: 3.086/0.02665 |
RGS3 | 2.661 | - | - | 0.920 | 0.989 | 0.752 | - | Mlig455_053523 {REF} {Length: 2125} {Pfam: Regulator of G protein signaling domain [PF00615.21, score=117.0]} {Human: ENSG00000138835, RGS3, regulator of G protein signaling 3, [RH, Score=163, Expect=4e-45]} {Mouse: ENSMUSG00000059810, Rgs3, regulator of G-protein signaling 3, [RH, Score=165, Expect=2e-45]} {Dmel: FBgn0028743, Dhit, Double hit, [Score=109, Expect=2e-27]} {Celegans: WBGene00004350, rgs-7, Regulator of G-protein signaling rgs-7, [RH, Score=130, Expect=1e-34]} {Smed: dd_Smed_v6_8787_0_1, dd_Smed_v6_8787_0_1, [Score=173, Expect=9e-51]} {RNA1310_19330.1} {RNA815_18723} Mlig455_061000 {REF} {Length: 2721} {Pfam: Regulator of G protein signaling domain [PF00615.21, score=117.0]; Dehydrin [PF00257.21, score=20.5]} {Human: ENSG00000138835, RGS3, regulator of G protein signaling 3, [RH, Score=163, Expect=4e-45]} {Mouse: ENSMUSG00000059810, Rgs3, regulator of G-protein signaling 3, [RH, Score=165, Expect=2e-45]} {Dmel: FBgn0028743, Dhit, Double hit, [Score=109, Expect=2e-27]} {Celegans: WBGene00004350, rgs-7, Regulator of G-protein signaling rgs-7, [RH, Score=130, Expect=1e-34]} {Smed: dd_Smed_v6_8787_0_1, dd_Smed_v6_8787_0_1, [Score=173, Expect=8e-51]} {RNA1310_19330.1} {RNA815_18723} |
51. | MligTC455_53869 | 27 | 0.57 | Mlig455_060247 | Neo: - Age: - |
CHDH | 2.661 | - | - | 0.892 | 0.965 | 0.804 | - | Mlig455_060247 {REF} {Length: 2837} {Pfam: GMC oxidoreductase [PF00732.21, score=82.3]; GMC oxidoreductase [PF05199.15, score=61.5]; FAD dependent oxidoreductase [PF01266.26, score=20.3]; Lycopene cyclase protein [PF05834.14, score=18.0]} {Human: ENSG00000016391, CHDH, choline dehydrogenase, [Score=101, Expect=6e-22]} {Mouse: ENSMUSG00000015970, Chdh, choline dehydrogenase, [Score=103, Expect=9e-23]} {Dmel: FBgn0037896, ninaG, [Score=116, Expect=3e-27]} {Celegans: WBGene00007917, C34C6.4, [Score=65.9, Expect=4e-11]} {Smed: dd_Smed_v6_13047_0_2, dd_Smed_v6_13047_0_2, [RH, Score=166, Expect=2e-44]} {RNA1310_47881.1} |
52. | MligTC455_13902 | 400 | 8.32 | Mlig455_011022, Mlig455_011835, Mlig455_013117 | Neo: - Age: Down-Up-Down, logFC(26M/2M)=-0.562 Region-specific R2: 6.064 Region-enriched R2: 5.080/0.00072 |
2.657 | - | - | 0.954 | 0.974 | 0.729 | - | Mlig455_011022 {REF} {Length: 631} {RNA1509_28527} {RNA1310_38436.1} {RNA815_28856} Mlig455_011835 {REF} {Length: 2387} {RNA1509_28527} {RNA1310_38436.1} {RNA815_28856} Mlig455_013117 {REF} {Length: 1663} {NoTransDecoderORF} {RNA1310_40518} {RNA815_20411.2} |
|
53. | MligTC455_50694 | 602 | 12.54 | Mlig455_058794, Mlig455_070066 | Neo: - Age: Down-Down-Up Region-specific R2: 5.478 Region-enriched R2: 3.805/0.01454 |
2.656 | - | - | 0.928 | 0.976 | 0.752 | - | Mlig455_058794 {REF} {Length: 776} {RNA1310_76208} {RNA815_49041} Mlig455_070066 {REF} {Length: 781} {RNA1310_76208} {RNA815_49041} |
|
54. | MligTC455_34369 | 112 | 2.34 | Mlig455_015308, Mlig455_015354, Mlig455_036248, Mlig455_068737, Mlig455_070110 | Neo: - Age: Up-Down-Up Region-enriched R2: 5.462/0.00546 |
2.653 | - | - | 0.800 | 0.875 | 0.978 | - | Mlig455_015308 {REF} {Length: 1459} {Pfam: Concanavalin A-like lectin/glucanases superfamily [PF13385.8, score=63.9]} {RNA1310_34740} {RNA815_15663} Mlig455_015354 {REF} {Length: 1446} {Pfam: Concanavalin A-like lectin/glucanases superfamily [PF13385.8, score=66.3]; Sialidase, N-terminal domain [PF02973.18, score=18.5]} {RNA1310_34740} {RNA815_15663} Mlig455_036248 {REF} {Length: 2111} {Pfam: Reverse transcriptase (RNA-dependent DNA polymerase) [PF00078.29, score=120.9]; Fibrinogen beta and gamma chains, C-terminal globular domain [PF00147.20, score=28.5]; PAN domain [PF00024.28, score=19.9]} {RNA1509_45496} {RNA1310_2539.1} {RNA815_252.1} Mlig455_068737 {REF} {Length: 1096} {Pfam: Concanavalin A-like lectin/glucanases superfamily [PF13385.8, score=68.3]; Sialidase, N-terminal domain [PF02973.18, score=19.9]} {RNA1310_34740} {RNA815_37905} Mlig455_070110 {REF} {Length: 1340} {Pfam: Reverse transcriptase (RNA-dependent DNA polymerase) [PF00078.29, score=109.6]} {RNA1509_32599} {RNA1310_1659} {RNA815_252.1} |
|
55. | MligTC455_25113 | 762 | 15.87 | Mlig455_020768 | Neo: - Age: Down-Up-Down Region-enriched R7: 2.653/0.00004 |
2.651 | - | - | 0.787 | 0.951 | 0.913 | - | Mlig455_020768 {REF} {Length: 810} {Celegans: WBGene00003748, nlp-10, Neuropeptide-Like Protein, [Score=46.2, Expect=1e-06]} {RNA1509_36958} {RNA1310_50245} {RNA815_48543} | |
56. | MligTC455_53546 | 130 | 2.72 | Mlig455_013326, Mlig455_013334 | Neo: - Age: - Region-enriched R2: 6.753/0.01892 |
MMP9 | 2.65 | - | - | 0.907 | 0.996 | 0.747 | - | Mlig455_013326 {REF} {Length: 1449} {Pfam: Fibronectin type II domain [PF00040.21, score=92.5]} {Human: ENSG00000100985, MMP9, matrix metallopeptidase 9, [RH, Score=87.8, Expect=3e-18]} {Mouse: ENSMUSG00000017737, Mmp9, matrix metallopeptidase 9, [RH, Score=82.4, Expect=1e-16]; ENSMUSG00000031740, Mmp2, matrix metallopeptidase 2, [RH, Score=78.6, Expect=2e-15]} {Smed: dd_Smed_v6_14558_0_1, dd_Smed_v6_14558_0_1, [RH, Score=138, Expect=3e-38]} {RNA1310_38631} {RNA815_51136} Mlig455_013334 {REF} {Length: 1398} {Pfam: Fibronectin type II domain [PF00040.21, score=92.1]} {Human: ENSG00000100985, MMP9, matrix metallopeptidase 9, [RH, Score=89.4, Expect=1e-18]} {Mouse: ENSMUSG00000017737, Mmp9, matrix metallopeptidase 9, [RH, Score=84.0, Expect=4e-17]} {Smed: dd_Smed_v6_12601_0_1, dd_Smed_v6_12601_0_1, [RH, Score=140, Expect=2e-38]} {RNA1310_38631} {RNA815_51136} |
57. | MligTC455_23220 | 56 | 1.18 | Mlig455_060190 | Neo: - Age: - |
ACKR3 | 2.648 | - | - | 0.911 | 0.963 | 0.774 | - | Mlig455_060190 {REF} {Length: 2108} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=106.0]} {Human: ENSG00000144476, ACKR3, atypical chemokine receptor 3, [RH, Score=99.0, Expect=1e-22]} {Mouse: ENSMUSG00000026180, Cxcr2, chemokine (C-X-C motif) receptor 2, [Score=112, Expect=1e-27]} {Dmel: FBgn0266429, AstA-R1, Allatostatin A receptor 1, [Score=102, Expect=4e-24]} {Celegans: WBGene00021439, ckr-2, CholecystoKinin Receptor homolog; Cholecystokinin receptor 2 splice isoform b, [Score=68.2, Expect=2e-12]} {Smed: dd_Smed_v6_10325_0_1, dd_Smed_v6_10325_0_1, [Score=81.6, Expect=5e-17]} {RNA1310_66504} {RNA815_39432} |
58. | MligTC455_41815 | 3865 | 80.51 | Mlig455_009140 | Neo: - Age: Down-Up-Up, logFC(26M/2M)=0.313 Region-specific R2: 4.291 Region-enriched R2: 4.068/0.00000 |
2.648 | - | - | 0.967 | 0.956 | 0.725 | - | Mlig455_009140 {REF} {Length: 772} {RNA1509_22527} {RNA1310_51112, RNA1509_22527} {RNA1509_22527, RNA815_25235.1} | |
59. | MligTC455_16329 | 1019 | 21.23 | Mlig455_007993 | Neo: - Age: - Region-specific R2: 3.685 Region-enriched R2: 3.576/0.00000 |
2.645 | - | - | 0.977 | 0.935 | 0.733 | - | Mlig455_007993 {REF} {Length: 635} {RNA1509_22236} {RNA1310_84275, RNA1509_22236} {RNA1509_22236, RNA815_43046} | |
60. | MligTC455_44966 | 574 | 11.95 | Mlig455_036578, Mlig455_057773 | Neo: - Age: Down-Down-Up, logFC(26M/2M)=-0.756 Region-specific R2: 7.016 Region-enriched R2: 7.690/0.00000 |
2.644 | - | - | 0.939 | 0.975 | 0.730 | - | Mlig455_036578 {REF} {Length: 1101} {RNA1509_34765} {RNA1310_57079} {RNA815_29388} Mlig455_057773 {REF} {Length: 629} {RNA1509_34765} {RNA1310_57079, RNA1509_34765} {RNA1509_34765, RNA815_29388} |
|
61. | MligTC455_42514 | 28 | 0.59 | Mlig455_027746 | Neo: - Age: Up-Down-Down |
KCNC2 | 2.641 | - | - | 0.915 | 0.764 | 0.962 | - | Mlig455_027746 {REF} {Length: 2596} {Pfam: Ion transport protein [PF00520.33, score=123.8]; BTB/POZ domain [PF02214.24, score=86.8]; Ion channel [PF07885.18, score=37.1]} {Human: ENSG00000166006, KCNC2, potassium voltage-gated channel subfamily C member 2, [Score=284, Expect=2e-86]; ENSG00000129159, KCNC1, potassium voltage-gated channel subfamily C member 1, [Score=279, Expect=3e-85]; ENSG00000116396, KCNC4, potassium voltage-gated channel subfamily C member 4, [Score=270, Expect=2e-81]} {Mouse: ENSMUSG00000058975, Kcnc1, potassium voltage gated channel, Shaw-related subfamily, member 1, [Score=279, Expect=3e-85]; ENSMUSG00000035681, Kcnc2, potassium voltage gated channel, Shaw-related subfamily, member 2, [Score=270, Expect=2e-81]} {Dmel: FBgn0003386, Shaw, Shaker cognate w, [Score=280, Expect=7e-87]} {Celegans: WBGene00008819, shw-1, SHaW family of potassium channels, [Score=303, Expect=3e-94]} {Smed: dd_Smed_v6_13250_0_1, dd_Smed_v6_13250_0_1, [Score=286, Expect=3e-88]} {RNA1509_33421} {RNA1310_15684} {RNA815_16308} |
62. | MligTC455_38657 | 292 | 6.08 | Mlig455_021581 | Neo: - Age: - |
CPLX1 | 2.64 | - | - | 0.849 | 0.817 | 0.974 | - | Mlig455_021581 {REF} {Length: 2085} {Pfam: Synaphin protein [PF05835.14, score=132.9]} {Human: ENSG00000168993, CPLX1, complexin 1, [Score=52.4, Expect=8e-09]; ENSG00000145920, CPLX2, complexin 2, [Score=50.8, Expect=1e-08]} {Mouse: ENSMUSG00000033615, Cplx1, complexin 1, [Score=53.5, Expect=2e-09]} {Dmel: FBgn0041605, cpx, complexin, [RH, Score=90.1, Expect=1e-23]} {Celegans: WBGene00022271, cpx-1, Putative complexin-1, [RH, Score=99.4, Expect=2e-27]} {Smed: dd_Smed_v6_9918_0_1, dd_Smed_v6_9918_0_1, [Score=94.4, Expect=2e-25]} {RNA1509_37151, RNA1509_38047} {RNA1310_51275, RNA1509_38047} {RNA1509_38047, RNA815_22799} |
63. | MligTC455_48935 | 27 | 0.57 | Mlig455_041669 | Neo: - Age: - |
2.639 | - | - | 0.860 | 0.995 | 0.784 | - | Mlig455_041669 {REF} {Length: 1052} {Smed: dd_Smed_v6_3795_0_1, dd_Smed_v6_3795_0_1, [Score=56.2, Expect=8e-10]} {RNA1310_58309} {RNA815_39074} | |
64. | MligTC455_45913 | 4034 | 84.05 | Mlig455_017927 | Neo: - Age: Down-Up-Up Region-specific R2: 3.031 Region-enriched R2: 2.341/0.00000 Regeneration-downregulated BL: -1.976 Regeneration-depleted BL: -1.976 |
2.637 | - | - | 0.904 | 0.972 | 0.761 | - | Mlig455_017927 {REF} {Length: 1006} {RNA1509_22540, RNA1509_32903, RNA1509_3805} {RNA1310_38334, RNA1509_22540, RNA1509_32903, RNA1509_3805} {RNA1509_22540, RNA1509_32903, RNA1509_3805, RNA815_18393} | |
65. | MligTC455_27678 | 355 | 7.4 | Mlig455_070610 | Neo: - Age: - Region-specific R2: 4.724 Region-enriched R2: 3.766/0.00062 |
2.636 | - | - | 0.976 | 0.947 | 0.713 | - | Mlig455_070610 {REF} {Length: 725} {RNA1509_17468, RNA1509_34237} {RNA1310_59474, RNA1509_17468, RNA1509_34237} {RNA1509_17468, RNA1509_34237, RNA815_28024} | |
66. | MligTC455_17561 | 189 | 3.94 | Mlig455_020268 | Neo: - Age: - Region-enriched R2: 4.198/0.00004 |
NECAB3 | 2.634 | - | - | 0.732 | 0.956 | 0.946 | - | Mlig455_020268 {REF} {Length: 1518} {Pfam: EF hand [PF00036.34, score=34.0]; EF-hand domain [PF13405.8, score=33.4]; EF-hand domain pair [PF13833.8, score=29.2]; EF-hand domain pair [PF13499.8, score=28.3]; Antibiotic biosynthesis monooxygenase [PF03992.18, score=22.0]; EF hand [PF13202.8, score=21.3]} {Human: ENSG00000125967, NECAB3, N-terminal EF-hand calcium binding protein 3, [RH, Score=189, Expect=7e-57]; ENSG00000123119, NECAB1, N-terminal EF-hand calcium binding protein 1, [RH, Score=186, Expect=1e-55]} {Mouse: ENSMUSG00000040536, Necab1, N-terminal EF-hand calcium binding protein 1, [RH, Score=192, Expect=6e-58]; ENSMUSG00000027489, Necab3, N-terminal EF-hand calcium binding protein 3, [RH, Score=191, Expect=9e-58]} {RNA1509_46831} {RNA1310_24461, RNA1509_46831} {RNA1509_46831, RNA815_25216} |
67. | MligTC455_41816 | 3808 | 79.33 | Mlig455_009585 | Neo: - Age: - Region-specific R2: 4.267 Region-enriched R2: 4.066/0.00000 |
2.628 | - | - | 0.962 | 0.955 | 0.711 | - | Mlig455_009585 {REF} {Length: 1833} {RNA1509_22527} {RNA1310_51112} {RNA815_25235.1} | |
68. | MligTC455_40872 | 71 | 1.48 | Mlig455_029550, Mlig455_040459, Mlig455_043605 | Neo: - Age: - |
2.623 | - | - | 0.844 | 0.803 | 0.976 | - | Mlig455_029550 {REF} {Length: 1370} {Pfam: Globin [PF00042.24, score=35.2]} {RNA1310_33016} {RNA815_22300} Mlig455_040459 {REF} {Length: 1083} {Pfam: Globin [PF00042.24, score=53.9]} {RNA1310_33016} {RNA815_22300} Mlig455_043605 {REF} {Length: 1424} {Pfam: Globin [PF00042.24, score=53.9]} {RNA1509_4190} {RNA1310_33016} {RNA815_22300} |
|
69. | MligTC455_46543 | 178 | 3.7 | Mlig455_000344, Mlig455_067946 | Neo: - Age: - Region-specific R2: 6.098 Region-enriched R2: 6.851/0.00000 |
2.62 | - | - | 0.977 | 0.936 | 0.707 | - | Mlig455_000344 {REF} {Length: 1920} {RNA1310_82457} {RNA815_33120} Mlig455_067946 {REF} {Length: 1217} {RNA1310_99435} |
|
70. | MligTC455_51806 | 83 | 1.73 | Mlig455_037702, Mlig455_046362 | Neo: - Age: - |
GPSM2 | 2.62 | - | - | 0.915 | 0.981 | 0.724 | - | Mlig455_037702 {REF} {Length: 3216} {Pfam: Tetratricopeptide repeat [PF13424.8, score=100.7]; Tetratricopeptide repeat [PF13176.8, score=98.7]; Tetratricopeptide repeat [PF00515.30, score=93.3]; GoLoco motif [PF02188.19, score=66.5]; Tetratricopeptide repeat [PF07719.19, score=54.7]; Tetratricopeptide repeat [PF13181.8, score=43.2]; Tetratricopeptide repeat [PF13374.8, score=34.5]; Rapsyn N-terminal myristoylation and linker region [PF10579.11, score=20.8]} {Human: ENSG00000121957, GPSM2, G protein signaling modulator 2, [RH, Score=521, Expect=3e-176]} {Mouse: ENSMUSG00000026930, Gpsm1, G-protein signalling modulator 1 (AGS3-like, C. elegans), [RH, Score=494, Expect=2e-166]} {Dmel: FBgn0040080, pins, partner of inscuteable, [RH, Score=534, Expect=0.0]} {Celegans: WBGene00000092, ags-3, Activator of G protein Signalling, [Score=256, Expect=4e-76]} {Smed: dd_Smed_v6_6548_1_1, dd_Smed_v6_6548_1_1, [RH, Score=462, Expect=3e-154]} {RNA1310_18538} {RNA815_41322} Mlig455_046362 {REF} {Length: 3324} {Pfam: Tetratricopeptide repeat [PF13424.8, score=119.4]; Tetratricopeptide repeat [PF13176.8, score=96.3]; Tetratricopeptide repeat [PF00515.30, score=93.0]; GoLoco motif [PF02188.19, score=85.6]; Tetratricopeptide repeat [PF07719.19, score=54.4]; Tetratricopeptide repeat [PF13181.8, score=42.7]; Tetratricopeptide repeat [PF13374.8, score=34.2]; Rapsyn N-terminal myristoylation and linker region [PF10579.11, score=21.7]} {Human: ENSG00000121957, GPSM2, G protein signaling modulator 2, [Score=545, Expect=0.0]} {Mouse: ENSMUSG00000027883, Gpsm2, G-protein signalling modulator 2 (AGS3-like, C. elegans), [RH, Score=535, Expect=0.0]} {Dmel: FBgn0040080, pins, partner of inscuteable, [RH, Score=531, Expect=1e-180]} {Celegans: WBGene00000092, ags-3, Activator of G protein Signalling, [RH, Score=266, Expect=1e-79]} {Smed: dd_Smed_v6_6548_1_1, dd_Smed_v6_6548_1_1, [RH, Score=474, Expect=1e-158]} {RNA1310_18538} {RNA815_41322} |
71. | MligTC455_53707 | 903 | 18.82 | Mlig455_001231 | Neo: - Age: Down-Up-Up Region-specific R2: 3.242 Region-enriched R2: 1.917/0.00133 Regeneration-downregulated BL: -2.295 Regeneration-depleted BL: -2.295 |
2.618 | - | - | 0.898 | 0.979 | 0.741 | - | Mlig455_001231 {REF} {Length: 737} {RNA1509_13584, RNA1509_53181, RNA1509_55651} {RNA1310_60643.1, RNA1509_13584, RNA1509_53181, RNA1509_55651} {RNA1509_13584, RNA1509_53181, RNA1509_55651, RNA815_32307.1} | |
72. | MligTC455_52543 | 184 | 3.83 | Mlig455_034643, Mlig455_062632 | Neo: - Age: Down-Up-Up Region-enriched R2: 4.879/0.00387 |
2.617 | - | - | 0.910 | 0.966 | 0.741 | - | Mlig455_034643 {REF} {Length: 690} {Pfam: Dickkopf N-terminal cysteine-rich region [PF04706.14, score=19.5]} {RNA1310_10592.1} {RNA815_59658} Mlig455_062632 {REF} {Length: 685} {Pfam: Dickkopf N-terminal cysteine-rich region [PF04706.14, score=19.5]} {RNA1310_10592.1} {RNA815_59658} |
|
73. | MligTC455_53415 | 319 | 6.64 | Mlig455_053444 | Neo: - Age: Up-Down-Down Region-specific R2: 4.862 Region-enriched R2: 4.179/0.00011 |
RP1 | 2.615 | - | - | 0.981 | 0.830 | 0.804 | - | Mlig455_053444 {REF} {Length: 4944} {Pfam: PLAT/LH2 domain [PF01477.25, score=155.3]; Doublecortin [PF03607.19, score=100.5]; Embryo-specific protein 3, (ATS3) [PF06232.13, score=22.5]; Fibroblast growth factor [PF00167.20, score=18.6]} {Human: ENSG00000104237, RP1, RP1, axonemal microtubule associated, [Score=471, Expect=6e-145]} {Mouse: ENSMUSG00000025900, Rp1, retinitis pigmentosa 1 (human), [Score=453, Expect=3e-136]} {Dmel: FBgn0261387, CG17528, [Score=56.6, Expect=1e-07]} {Celegans: WBGene00006993, zyg-8, Serine/threonine-protein kinase zyg-8, [Score=75.9, Expect=1e-13]} {Smed: dd_Smed_v6_10315_0_2, dd_Smed_v6_10315_0_2, [Score=691, Expect=0.0]} {RNA1509_59703} {RNA1310_2710} {RNA815_17469} |
74. | MligTC455_45173 | 1421 | 29.61 | Mlig455_000256 | Neo: - Age: Up-Down-Up Region-enriched R2: 2.313/0.00035 |
2.614 | - | - | 0.741 | 0.952 | 0.921 | - | Mlig455_000256 {REF} {Length: 574} {RNA1509_48066} {RNA1310_71808.1} {RNA815_32033} | |
75. | MligTC455_45174 | 1447 | 30.15 | Mlig455_058539 | Neo: - Age: - Region-enriched R2: 2.293/0.00024 |
MLX | 2.609 | - | - | 0.737 | 0.952 | 0.920 | - | Mlig455_058539 {REF} {Length: 4178} {Pfam: Helix-loop-helix DNA-binding domain [PF00010.28, score=41.6]} {Human: ENSG00000108788, MLX, MLX, MAX dimerization protein, [RH, Score=145, Expect=5e-42]} {Mouse: ENSMUSG00000017801, Mlx, MAX-like protein X, [RH, Score=144, Expect=8e-42]} {Dmel: FBgn0039509, bigmax, [RH, Score=130, Expect=2e-36]} {Smed: dd_Smed_v6_3140_0_1, dd_Smed_v6_3140_0_1, [RH, Score=163, Expect=3e-48]} {RNA1509_10793} {RNA1310_22883.1, RNA1509_10793} {RNA1509_10793, RNA815_10829} |
76. | MligTC455_15184 | 33 | 0.69 | Mlig455_065087 | Neo: - Age: - |
2.608 | - | - | 0.963 | 0.918 | 0.727 | - | Mlig455_065087 {REF} {Length: 2555} {Pfam: Amiloride-sensitive sodium channel [PF00858.26, score=183.3]} {Mouse: ENSMUSG00000030340, Scnn1a, sodium channel, nonvoltage-gated 1 alpha, [Score=48.5, Expect=1e-05]} {Celegans: WBGene00009073, delm-1, DEgenerin Linked to Mechanosensation, [Score=68.2, Expect=1e-11]} {Smed: dd_Smed_v6_37545_0_1, dd_Smed_v6_37545_0_1, [RH, Score=125, Expect=3e-30]} {RNA1310_11413} {RNA815_11497} | |
77. | MligTC455_47716 | 1445 | 30.1 | Mlig455_062374, Mlig455_062397 | Neo: - Age: Down-Up-Up Region-specific R2: 4.444 Region-enriched R2: 3.549/0.00000 |
2.605 | - | - | 0.846 | 0.961 | 0.798 | - | Mlig455_062374 {REF} {Length: 899} {RNA1509_16194} {RNA1310_50819.1} {RNA815_25538} Mlig455_062397 {REF} {Length: 907} {RNA1509_16194} {RNA1310_50819.1, RNA1509_16194} {RNA1509_16194, RNA815_25538} |
|
78. | MligTC455_35258 | 2779 | 57.89 | Mlig455_040964 | Neo: - Age: Up-Down-Down Region-specific R2: 2.469 Region-enriched R2: 1.501/0.00133 |
2.604 | - | - | 0.857 | 0.773 | 0.974 | - | Mlig455_040964 {REF} {Length: 8259} {Smed: dd_Smed_v6_8425_0_1, dd_Smed_v6_8425_0_1, [Score=543, Expect=9e-160]} {RNA1509_16633, RNA1509_52679} {RNA1310_236.2, RNA1509_16633} {RNA1509_16633, RNA815_77.1} | |
79. | MligTC455_49073 | 824 | 17.17 | Mlig455_063174 | Neo: - Age: Down-Down-Up Region-specific R2: 4.151 Region-enriched R2: 3.105/0.00023 |
2.599 | - | - | 0.886 | 0.950 | 0.763 | - | Mlig455_063174 {REF} {Length: 1083} {RNA1509_9056} {RNA1310_56777} {RNA815_24608} | |
80. | MligTC455_40867 | 6445 | 134.27 | Mlig455_005155, Mlig455_021617 | Neo: - Age: Down-Up-Up Region-specific R2: 3.705 Region-enriched R2: 2.406/0.00000 Regeneration-depleted BL: -3.516 |
2.596 | - | - | 0.861 | 0.984 | 0.751 | - | Mlig455_005155 {REF} {Length: 850} {RNA1509_3536} {RNA1310_30272} {RNA815_20224} Mlig455_021617 {REF} {Length: 851} {RNA1509_3536} {RNA1310_30272} {RNA815_20224} |
|
81. | MligTC455_38942 | 10049 | 209.36 | Mlig455_006199, Mlig455_059287, Mlig455_065208 | Neo: - Age: Down-Up-Up Region-specific R2: 3.098 Region-enriched R2: 2.386/0.00000 Regeneration-downregulated BL: -1.590 Regeneration-depleted BL: -1.590 |
2.595 | - | - | 0.874 | 0.973 | 0.748 | - | Mlig455_006199 {REF} {Length: 1471} {Pfam: Insulin/IGF/Relaxin family [PF00049.20, score=24.5]; PBCV-specific basic adaptor domain [PF08789.12, score=19.4]} {RNA1509_46453} {RNA1310_48530} {RNA815_23319.1} Mlig455_059287 {REF} {Length: 4862} {Pfam: Insulin/IGF/Relaxin family [PF00049.20, score=25.9]} {RNA1509_58881} {RNA1310_67941, RNA1509_58881} {RNA1509_58881, RNA815_23357} Mlig455_065208 {REF} {Length: 981} {Pfam: Pheromone biosynthesis activating neuropeptide (PBAN) [PF05874.13, score=24.3]} {RNA1509_18071, RNA1509_58881} {RNA1310_48530, RNA1509_18071} {RNA1509_18071, RNA815_23319.1} |
|
82. | MligTC455_50566 | 40 | 0.84 | Mlig455_061499 | Neo: - Age: - Region-enriched R2: 5.243/0.02447 |
2.588 | - | - | 0.727 | 0.895 | 0.966 | - | Mlig455_061499 {REF} {Length: 484} {NoTransDecoderORF} {RNA1310_94077} {RNA815_47403} | |
83. | MligTC455_10899 | 46 | 0.95 | Mlig455_013784, Mlig455_013915 | Neo: - Age: - |
2.582 | - | - | 0.706 | 0.953 | 0.923 | - | Mlig455_013784 {REF} {Length: 1362} {Pfam: Glycine rich protein [PF12810.9, score=20.8]} {RNA1509_28715} {RNA1310_91773} {RNA815_35307} Mlig455_013915 {REF} {Length: 1516} {Pfam: Glycine rich protein [PF12810.9, score=20.3]} {RNA1509_28715} {RNA1310_91773} {RNA815_35307} |
|
84. | MligTC455_19876 | 135 | 2.82 | Mlig455_024520, Mlig455_024523 | Neo: - Age: - |
2.579 | - | - | 0.978 | 0.874 | 0.727 | - | Mlig455_024520 {REF} {Length: 2352} {Pfam: CD20-like family [PF04103.17, score=40.9]} {Mouse: ENSMUSG00000048004, Tmem196, transmembrane protein 196, [Score=63.5, Expect=2e-12]} {Smed: dd_Smed_v6_14043_0_1, dd_Smed_v6_14043_0_1, [Score=184, Expect=5e-59]} {RNA1509_25506} {RNA1310_9338} {RNA815_23744} Mlig455_024523 {REF} {Length: 2311} {Smed: dd_Smed_v6_14043_0_1, dd_Smed_v6_14043_0_1, [Score=153, Expect=3e-47]} {RNA1509_25506} {RNA1310_9338} {RNA815_23744} |
|
85. | MligTC455_42314 | 406 | 8.46 | Mlig455_052727 | Neo: - Age: - Region-enriched R2: 4.230/0.00183 |
2.577 | - | - | 0.861 | 0.997 | 0.719 | - | Mlig455_052727 {REF} {Length: 1339} {Pfam: Hyaluronidase protein (HylP) [PF07212.13, score=19.1]} {RNA1509_51722} {RNA1310_50605} {RNA815_15783.1} | |
86. | MligTC455_20757 | 286 | 5.96 | Mlig455_005125, Mlig455_005185 | Neo: - Age: - |
2.573 | - | - | 0.819 | 0.972 | 0.782 | - | Mlig455_005125 {REF} {Length: 1290} {RNA1310_29676.2} {RNA815_31533} Mlig455_005185 {REF} {Length: 1357} {RNA1310_29676.1} {RNA815_31533} |
|
87. | MligTC455_17701 | 1279 | 26.65 | Mlig455_051483 | Neo: - Age: Down-Up-Up Region-specific R2: 5.592 Region-enriched R2: 6.602/0.00000 |
2.565 | - | - | 0.722 | 0.880 | 0.963 | - | Mlig455_051483 {REF} {Length: 1833} {RNA1509_14131} {RNA1310_69964.2, RNA1509_14131} {RNA1509_14131, RNA815_35453.1} | |
88. | MligTC455_18333 | 273 | 5.7 | Mlig455_010935 | Neo: - Age: Down-Up-Up Region-enriched R2: 5.059/0.00307 |
2.565 | - | - | 0.795 | 0.981 | 0.789 | - | Mlig455_010935 {REF} {Length: 510} {RNA1310_33328.2} {RNA815_15093.1} | |
89. | MligTC455_27025 | 706 | 14.7 | Mlig455_054786, Mlig455_054878 | Neo: - Age: - Region-enriched R2: 3.519/0.00005 |
CD82 | 2.564 | - | - | 0.750 | 0.846 | 0.968 | - | Mlig455_054786 {REF} {Length: 2796} {Pfam: Tetraspanin family [PF00335.22, score=142.8]} {Human: ENSG00000085117, CD82, CD82 molecule, [RH, Score=86.3, Expect=4e-19]} {Mouse: ENSMUSG00000027215, Cd82, CD82 antigen, [RH, Score=94.0, Expect=3e-22]} {Dmel: FBgn0035936, Tsp66E, Tetraspanin 66E, [Score=98.6, Expect=6e-24]} {Celegans: WBGene00006632, tsp-6, Tetraspanin, [Score=74.7, Expect=1e-15]} {Smed: dd_Smed_v6_13639_0_1, dd_Smed_v6_13639_0_1, [RH, Score=160, Expect=2e-47]} {RNA1509_20389, RNA1509_43644, RNA1509_56428} {RNA1310_8032.1, RNA1509_20389, RNA1509_43644, RNA1509_56428} {RNA1509_20389, RNA1509_43644, RNA1509_56428, RNA815_3380.1} Mlig455_054878 {REF} {Length: 4398} {Pfam: Tetraspanin family [PF00335.22, score=143.7]} {Human: ENSG00000085117, CD82, CD82 molecule, [RH, Score=84.7, Expect=2e-18]} {Mouse: ENSMUSG00000027215, Cd82, CD82 antigen, [RH, Score=92.4, Expect=2e-21]} {Dmel: FBgn0035936, Tsp66E, Tetraspanin 66E, [Score=99.8, Expect=4e-24]} {Celegans: WBGene00006643, tsp-17, TetraSPanin family, [RH, Score=73.2, Expect=1e-14]} {Smed: dd_Smed_v6_13639_0_1, dd_Smed_v6_13639_0_1, [RH, Score=160, Expect=2e-47]} {RNA1509_56428} {RNA1310_8032.2} {RNA815_3380.1} |
90. | MligTC455_37431 | 35 | 0.74 | Mlig455_021017 | Neo: - Age: - |
TMEM268 | 2.563 | - | - | 0.769 | 0.982 | 0.812 | - | Mlig455_021017 {REF} {Length: 1973} {Pfam: Domain of unknown function (DUF4481) [PF14800.8, score=60.3]} {Human: ENSG00000157693, TMEM268, transmembrane protein 268, [Score=52.8, Expect=6e-07]} {Mouse: ENSMUSG00000045917, Tmem268, transmembrane protein 268, [Score=58.2, Expect=8e-09]} {Dmel: FBgn0028527, CG18507, [Score=55.1, Expect=8e-08]} {RNA1310_62734} {RNA815_60695} |
91. | MligTC455_11776 | 33 | 0.68 | Mlig455_048959 | Neo: - Age: - |
GABBR2 | 2.56 | - | - | 0.868 | 0.978 | 0.714 | - | Mlig455_048959 {REF} {Length: 2499} {Pfam: 7 transmembrane sweet-taste receptor of 3 GCPR [PF00003.24, score=162.7]; Receptor family ligand binding region [PF01094.30, score=94.2]} {Human: ENSG00000136928, GABBR2, gamma-aminobutyric acid type B receptor subunit 2, [Score=277, Expect=2e-80]} {Mouse: ENSMUSG00000039809, Gabbr2, gamma-aminobutyric acid (GABA) B receptor, 2, [Score=273, Expect=5e-79]} {Dmel: FBgn0260446, GABA-B-R1, metabotropic GABA-B receptor subtype 1, [Score=252, Expect=4e-72]} {Celegans: WBGene00021528, gbb-1, GABA B receptor subunit; GABAB1 receptor subunit, [Score=251, Expect=6e-72]} {Smed: dd_Smed_v6_51663_0_1, dd_Smed_v6_51663_0_1, [Score=134, Expect=4e-35]} {RNA1310_72017} {RNA815_50524} |
92. | MligTC455_24985 | 43 | 0.89 | Mlig455_005348, Mlig455_005464 | Neo: - Age: - |
ADRA1A, HTR1A | 2.559 | - | - | 0.834 | 0.955 | 0.770 | - | Mlig455_005348 {REF} {Length: 1845} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=222.9]; Serpentine type 7TM GPCR chemoreceptor Srsx [PF10320.11, score=41.4]} {Human: ENSG00000120907, ADRA1A, adrenoceptor alpha 1A, [Score=186, Expect=3e-54]; ENSG00000178394, HTR1A, 5-hydroxytryptamine receptor 1A, [Score=184, Expect=1e-53]; ENSG00000170214, ADRA1B, adrenoceptor alpha 1B, [Score=179, Expect=1e-50]} {Mouse: ENSMUSG00000045875, Adra1a, adrenergic receptor, alpha 1a, [Score=181, Expect=1e-52]; ENSMUSG00000021721, Htr1a, 5-hydroxytryptamine (serotonin) receptor 1A, [Score=179, Expect=5e-52]; ENSMUSG00000050541, Adra1b, adrenergic receptor, alpha 1b, [Score=179, Expect=7e-51]} {Dmel: FBgn0011582, Dop1R1, Dopamine 1-like receptor 1, [Score=162, Expect=3e-45]} {Celegans: WBGene00004777, ser-2, Tyramine receptor Ser-2, [Score=181, Expect=7e-53]} {Smed: dd_Smed_v6_33950_0_1, dd_Smed_v6_33950_0_1, [Score=254, Expect=1e-80]} {RNA1310_56787} Mlig455_005464 {REF} {Length: 1742} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=223.9]; Serpentine type 7TM GPCR chemoreceptor Srsx [PF10320.11, score=43.6]; Serpentine type 7TM GPCR chemoreceptor Srx [PF10328.11, score=21.7]; Presenilin [PF01080.19, score=17.5]} {Human: ENSG00000178394, HTR1A, 5-hydroxytryptamine receptor 1A, [Score=194, Expect=7e-57]; ENSG00000150594, ADRA2A, adrenoceptor alpha 2A, [Score=191, Expect=4e-55]} {Mouse: ENSMUSG00000058620, Adra2b, adrenergic receptor, alpha 2b, [RH, Score=184, Expect=5e-53]} {Dmel: FBgn0053517, Dop2R, Dopamine 2-like receptor, [Score=172, Expect=1e-46]} {Celegans: WBGene00017157, tyra-2, Tyramine receptor tyra-2, [RH, Score=216, Expect=3e-65]} {Smed: dd_Smed_v6_33950_0_1, dd_Smed_v6_33950_0_1, [RH, Score=329, Expect=1e-108]} {RNA1310_56787} |
93. | MligTC455_47190 | 3794 | 79.04 | Mlig455_044419, Mlig455_044420, Mlig455_044455 | Neo: - Age: - Region-enriched R8: 3.373/0.00004 |
2.557 | - | - | 0.711 | 0.854 | 0.992 | - | Mlig455_044419 {REF} {Length: 1036} {RNA1509_30179} {RNA1310_60147} {RNA815_30734} Mlig455_044420 {REF} {Length: 1088} {RNA1509_30179} {RNA1310_60147} {RNA815_30734} Mlig455_044455 {REF} {Length: 1883} {Smed: dd_Smed_v6_1588_0_1, dd_Smed_v6_1588_0_1, [Score=41.2, Expect=6e-06]} {RNA1509_30179} {RNA1310_60147, RNA1509_30179} {RNA1509_30179, RNA815_30734} |
|
94. | MligTC455_41035 | 366 | 7.62 | Mlig455_000866 | Neo: - Age: logFC(26M/2M)=-0.773 Region-specific R2: 5.029 Region-enriched R2: 4.768/0.00000 |
2.555 | - | - | 0.833 | 0.975 | 0.747 | - | Mlig455_000866 {REF} {Length: 1126} {Pfam: Pancreatic hormone peptide [PF00159.20, score=41.6]} {RNA1509_27581} {RNA1310_74103, RNA1509_27581} {RNA1509_27581, RNA815_38377} | |
95. | MligTC455_16358 | 1175 | 24.47 | Mlig455_039878 | Neo: - Age: - Region-specific R2: 4.659 Region-enriched R2: 4.310/0.00000 |
2.554 | - | - | 0.826 | 0.969 | 0.759 | - | Mlig455_039878 {REF} {Length: 1188} {RNA1509_60020} {RNA1310_35099.1, RNA1509_60020} {RNA1509_60020, RNA815_1356.1} | |
96. | MligTC455_47420 | 218 | 4.54 | Mlig455_017159, Mlig455_048110 | Neo: - Age: - Region-specific R2: 6.469 Region-enriched R2: 5.851/0.00135 |
2.548 | - | - | 0.818 | 0.986 | 0.744 | - | Mlig455_017159 {REF} {Length: 1062} {RNA1509_35349} {RNA1310_81586} Mlig455_048110 {REF} {Length: 527} {RNA1310_81586} |
|
97. | MligTC455_19079 | 218 | 4.54 | Mlig455_008746, Mlig455_008760 | Neo: - Age: Down-Up-Up Region-specific R2: 6.705 Region-enriched R2: 6.864/0.00152 |
2.547 | - | - | 0.802 | 0.958 | 0.787 | - | Mlig455_008746 {REF} {Length: 652} {RNA1310_75395.1} {RNA815_42524} Mlig455_008760 {REF} {Length: 1051} {RNA1310_75395.1} {RNA815_42524} |
|
98. | MligTC455_04855 | 16 | 0.34 | Mlig455_005010, Mlig455_005053, Mlig455_005260 | Neo: - Age: logFC(26M/2M)=0.904 |
HCRTR2 | 2.547 | - | - | 0.753 | 0.986 | 0.808 | - | Mlig455_005010 {REF} {Length: 1532} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=156.6]; Serpentine type 7TM GPCR chemoreceptor Srw [PF10324.11, score=29.4]; Serpentine type 7TM GPCR chemoreceptor Srsx [PF10320.11, score=25.7]; Serpentine type 7TM GPCR chemoreceptor Srx [PF10328.11, score=23.9]} {Human: ENSG00000137252, HCRTR2, hypocretin receptor 2, [RH, Score=207, Expect=5e-61]} {Mouse: ENSMUSG00000032360, Hcrtr2, hypocretin (orexin) receptor 2, [Score=209, Expect=7e-62]} {Dmel: FBgn0038880, SIFaR, SIFamide receptor, [Score=150, Expect=8e-39]} {Celegans: WBGene00022004, npr-22, NeuroPeptide Receptor family, [Score=119, Expect=4e-29]} {Smed: dd_Smed_v6_22624_0_1, dd_Smed_v6_22624_0_1, [RH, Score=215, Expect=7e-65]} {RNA1310_58724} {RNA815_36016} Mlig455_005053 {REF} {Length: 3639} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=156.6]; Serpentine type 7TM GPCR chemoreceptor Srw [PF10324.11, score=29.4]; Serpentine type 7TM GPCR chemoreceptor Srsx [PF10320.11, score=25.7]; Serpentine type 7TM GPCR chemoreceptor Srx [PF10328.11, score=23.9]} {Human: ENSG00000137252, HCRTR2, hypocretin receptor 2, [RH, Score=210, Expect=6e-62]} {Mouse: ENSMUSG00000032360, Hcrtr2, hypocretin (orexin) receptor 2, [Score=211, Expect=1e-62]} {Dmel: FBgn0038880, SIFaR, SIFamide receptor, [Score=150, Expect=7e-39]} {Celegans: WBGene00022004, npr-22, NeuroPeptide Receptor family, [Score=119, Expect=3e-29]} {Smed: dd_Smed_v6_22624_0_1, dd_Smed_v6_22624_0_1, [RH, Score=215, Expect=6e-65]} {RNA1310_58724} {RNA815_36016} Mlig455_005260 {REF} {Length: 1614} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=156.6]; Serpentine type 7TM GPCR chemoreceptor Srw [PF10324.11, score=29.4]; Serpentine type 7TM GPCR chemoreceptor Srsx [PF10320.11, score=25.7]; Serpentine type 7TM GPCR chemoreceptor Srx [PF10328.11, score=23.9]} {Human: ENSG00000137252, HCRTR2, hypocretin receptor 2, [RH, Score=210, Expect=6e-62]} {Mouse: ENSMUSG00000032360, Hcrtr2, hypocretin (orexin) receptor 2, [Score=211, Expect=1e-62]} {Dmel: FBgn0038880, SIFaR, SIFamide receptor, [Score=150, Expect=7e-39]} {Celegans: WBGene00022004, npr-22, NeuroPeptide Receptor family, [Score=119, Expect=3e-29]} {Smed: dd_Smed_v6_22624_0_1, dd_Smed_v6_22624_0_1, [RH, Score=215, Expect=6e-65]} {RNA1310_58724} {RNA815_36016} |
99. | MligTC455_46430 | 62 | 1.29 | Mlig455_057117, Mlig455_069301 | Neo: - Age: - |
GUCY2F | 2.546 | - | - | 0.792 | 0.959 | 0.795 | - | Mlig455_057117 {REF} {Length: 2651} {Pfam: Adenylate and Guanylate cyclase catalytic domain [PF00211.22, score=196.0]; Nitrate and nitrite sensing [PF08376.12, score=82.5]; Heme NO binding associated [PF07701.16, score=28.2]} {Human: ENSG00000101890, GUCY2F, guanylate cyclase 2F, retinal, [Score=247, Expect=9e-70]; ENSG00000169418, NPR1, natriuretic peptide receptor 1, [Score=242, Expect=3e-68]; ENSG00000159899, NPR2, natriuretic peptide receptor 2, [Score=238, Expect=5e-67]} {Mouse: ENSMUSG00000042282, Gucy2f, guanylate cyclase 2f, [Score=246, Expect=7e-70]; ENSMUSG00000027931, Npr1, natriuretic peptide receptor 1, [Score=242, Expect=2e-68]; ENSMUSG00000020890, Gucy2e, guanylate cyclase 2e, [Score=241, Expect=7e-68]; ENSMUSG00000028469, Npr2, natriuretic peptide receptor 2, [Score=239, Expect=3e-67]} {Dmel: FBgn0053958, CG33958, [Score=266, Expect=4e-79]} {Celegans: WBGene00001547, gcy-22, Receptor-type guanylate cyclase gcy-22, [Score=235, Expect=3e-66]} {Smed: dd_Smed_v6_14331_0_1, dd_Smed_v6_14331_0_1, [Score=238, Expect=4e-67]} {RNA1509_38781} {RNA1310_35456} {RNA815_22108} Mlig455_069301 {REF} {Length: 2370} {Pfam: Adenylate and Guanylate cyclase catalytic domain [PF00211.22, score=178.1]; Nitrate and nitrite sensing [PF08376.12, score=82.3]; Heme NO binding associated [PF07701.16, score=28.0]} {Human: ENSG00000101890, GUCY2F, guanylate cyclase 2F, retinal, [Score=232, Expect=2e-64]} {Mouse: ENSMUSG00000042282, Gucy2f, guanylate cyclase 2f, [Score=232, Expect=1e-64]; ENSMUSG00000020890, Gucy2e, guanylate cyclase 2e, [Score=225, Expect=5e-62]} {Dmel: FBgn0053958, CG33958, [Score=250, Expect=5e-73]} {Celegans: WBGene00001547, gcy-22, Receptor-type guanylate cyclase gcy-22, [Score=223, Expect=1e-61]} {Smed: dd_Smed_v6_14331_0_1, dd_Smed_v6_14331_0_1, [Score=221, Expect=4e-61]} {RNA1509_38781} {RNA1310_35456} {RNA815_24181} |
100. | MligTC455_40063 | 1170 | 24.37 | Mlig455_005633, Mlig455_005677, Mlig455_008693 | Neo: - Age: Down-Up-Down, logFC(26M/2M)=-0.272 Region-specific R2: 8.260 Region-enriched R2: 8.105/0.00000 |
MAGEL2, TRO | 2.544 | - | - | 0.736 | 0.955 | 0.853 | - | Mlig455_005633 {REF} {Length: 2008} {Pfam: PMG protein [PF05287.14, score=47.1]} {Human: ENSG00000067445, TRO, trophinin, [Score=65.1, Expect=1e-10]} {RNA1509_11063} {RNA1310_60276} {RNA815_42200} Mlig455_005677 {REF} {Length: 1823} {Human: ENSG00000254585, MAGEL2, MAGE family member L2, [RH, Score=67.8, Expect=1e-12]} {RNA1509_11063} {RNA1310_60276} {RNA815_42200} Mlig455_008693 {REF} {Length: 1327} {Pfam: PMG protein [PF05287.14, score=30.5]} {RNA1509_11063} {RNA1310_60276} {RNA815_42200} |